Cargando…

Modelling endogenous insulin concentration in type 2 diabetes during closed-loop insulin delivery

BACKGROUND: Closed-loop insulin delivery is an emerging treatment for type 1 diabetes (T1D) evaluated clinically and using computer simulations during pre-clinical testing. Efforts to make closed-loop systems available to people with type 2 diabetes (T2D) calls for the development of a new type of s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ruan, Yue, Thabit, Hood, Wilinska, Malgorzata E, Hovorka, Roman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359432/ https://www.ncbi.nlm.nih.gov/pubmed/25889091 http://dx.doi.org/10.1186/s12938-015-0009-5

Ejemplares similares

Hypoglycaemia incidence and recovery during home use of hybrid closed‐loop insulin delivery in adults with type 1 diabetes
por: Ruan, Yue, et al.
Publicado: (2018)

Faster insulin action is associated with improved glycaemic outcomes during closed‐loop insulin delivery and sensor‐augmented pump therapy in adults with type 1 diabetes
por: Ruan, Yue, et al.
Publicado: (2017)

Closed-Loop Insulin Delivery During Pregnancy Complicated by Type 1 Diabetes
por: Murphy, Helen R., et al.
Publicado: (2011)

Impact of the CamAPS FX hybrid closed‐loop insulin delivery system on sleep traits in older adults with type 1 diabetes
por: Thabit, Hood, et al.
Publicado: (2022)

Closed-loop insulin delivery for treatment of type 1 diabetes
por: Elleri, Daniela, et al.
Publicado: (2011)

Overnight Closed-Loop Insulin Delivery in Young People With Type 1 Diabetes: A Free-Living, Randomized Clinical Trial
por: Hovorka, Roman, et al.
Publicado: (2014)

Pharmacokinetics of diluted (U20) insulin aspart compared with standard (U100) in children aged 3–6 years with type 1 diabetes during closed-loop insulin delivery: a randomised clinical trial
por: Ruan, Yue, et al.
Publicado: (2014)

Closed-loop for type 1 diabetes – an introduction and appraisal for the generalist
por: Bally, Lia, et al.
Publicado: (2017)

Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial
por: Tauschmann, Martin, et al.
Publicado: (2018)

Factors Associated With Glycemic Control During Free-Living Overnight Closed-Loop Insulin Delivery in Children and Adults With Type 1 Diabetes
por: Tauschmann, Martin, et al.
Publicado: (2015)

Day-and-night glycaemic control with closed-loop insulin delivery versus conventional insulin pump therapy in free-living adults with well controlled type 1 diabetes: an open-label, randomised, crossover study
por: Bally, Lia, et al.
Publicado: (2017)

Sensor Life and Overnight Closed Loop: A Randomized Clinical Trial
por: Tauschmann, Martin, et al.
Publicado: (2016)

Fully Closed-Loop Insulin Delivery in Patients Undergoing Pancreatic Surgery
por: Krutkyte, Gabija, et al.
Publicado: (2023)

Assessing the effectiveness of 3 months day and night home closed-loop insulin delivery in adults with suboptimally controlled type 1 diabetes: a randomised crossover study protocol
por: Leelarathna, Lalantha, et al.
Publicado: (2014)

Fully automated closed-loop insulin delivery in adults with type 2 diabetes: an open-label, single-center, randomized crossover trial
por: Daly, Aideen B., et al.
Publicado: (2023)

Closed‐loop insulin delivery in end‐of‐life care: a case report
por: Boughton, C. K., et al.
Publicado: (2019)

Closed-Loop Basal Insulin Delivery Over 36 Hours in Adolescents With Type 1 Diabetes: Randomized clinical trial
por: Elleri, Daniela, et al.
Publicado: (2013)

New closed-loop insulin systems
por: Boughton, Charlotte K., et al.
Publicado: (2021)

Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies
por: Hovorka, Roman, et al.
Publicado: (2011)

Lower plasma insulin levels during overnight closed-loop in school children with type 1 diabetes: Potential advantage? A randomized cross-over trial
por: Schierloh, Ulrike, et al.
Publicado: (2019)

Correction to: New closed-loop insulin systems
por: Boughton, Charlotte K., et al.
Publicado: (2021)

Behavioral Patterns and Associations with Glucose Control During 12-Week Randomized Free-Living Clinical Trial of Day and Night Hybrid Closed-Loop Insulin Delivery in Adults with Type 1 Diabetes
por: Emami, Ali, et al.
Publicado: (2017)

Safety and Efficacy of 24-h Closed-Loop Insulin Delivery in Well-Controlled Pregnant Women With Type 1 Diabetes: A randomized crossover case series
por: Murphy, Helen R., et al.
Publicado: (2011)

Fully automated closed-loop glucose control compared with standard insulin therapy in adults with type 2 diabetes requiring dialysis: an open-label, randomized crossover trial
por: Boughton, Charlotte K., et al.
Publicado: (2021)

Fully closed-loop insulin delivery in inpatients receiving nutritional support: a two-centre, open-label, randomised controlled trial
por: Boughton, Charlotte K, et al.
Publicado: (2019)

Hybrid closed-loop glucose control compared with sensor augmented pump therapy in older adults with type 1 diabetes: an open-label multicentre, multinational, randomised, crossover study
por: Boughton, Charlotte K, et al.
Publicado: (2022)

Adaptability of Closed Loop During Labor, Delivery, and Postpartum: A Secondary Analysis of Data from Two Randomized Crossover Trials in Type 1 Diabetes Pregnancy
por: Stewart, Zoe A., et al.
Publicado: (2018)

Publisher Correction: Fully automated closed-loop glucose control compared with standard insulin therapy in adults with type 2 diabetes requiring dialysis: an open-label, randomized crossover trial
por: Boughton, Charlotte K., et al.
Publicado: (2021)

Assessing the effect of closed-loop insulin delivery from onset of type 1 diabetes in youth on residual beta-cell function compared to standard insulin therapy (CLOuD study): a randomised parallel study protocol
por: Boughton, Charlotte, et al.
Publicado: (2020)

Basal insulin delivery reduction for exercise in type 1 diabetes: finding the sweet spot
por: Thabit, Hood, et al.
Publicado: (2016)

Coming of age: the artificial pancreas for type 1 diabetes
por: Thabit, Hood, et al.
Publicado: (2016)

Participants' Experiences of, and Views About, Daytime Use of a Day-and-Night Hybrid Closed-Loop System in Real Life Settings: Longitudinal Qualitative Study
por: Lawton, Julia, et al.
Publicado: (2019)

Closing the loop overnight at home setting: psychosocial impact for adolescents with type 1 diabetes and their parents
por: Barnard, Katharine D, et al.
Publicado: (2014)

Feasibility of fully automated closed-loop glucose control using continuous subcutaneous glucose measurements in critical illness: a randomized controlled trial
por: Leelarathna, Lalantha, et al.
Publicado: (2013)

Assessing the efficacy, safety and utility of 6-month day-and-night automated closed-loop insulin delivery under free-living conditions compared with insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, multicentre, multinational, single-period, randomised, parallel group study protocol
por: Musolino, Gianluca, et al.
Publicado: (2019)

Insulin delivery and nocturnal glucose control in children and adolescents with type 1 diabetes
por: Tauschmann, Martin, et al.
Publicado: (2017)

The changing landscape of automated insulin delivery in the management of type 1 diabetes
por: Lakshman, Rama, et al.
Publicado: (2023)

Bolusing frequency and amount impacts glucose control during hybrid closed‐loop
por: Bally, L., et al.
Publicado: (2017)

The impact of using a closed‐loop system on food choices and eating practices among people with Type 1 diabetes: a qualitative study involving adults, teenagers and parents
por: Lawton, J., et al.
Publicado: (2019)

Day and Night Closed-Loop Control in Adults With Type 1 Diabetes: A comparison of two closed-loop algorithms driving continuous subcutaneous insulin infusion versus patient self-management
por: Luijf, Yoeri M., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_a1evllmekfm93glmr2ap5dj6k7